Details
 

August 13 (5:00PM) - 19 (9:00PM), 2020

National Broadcast to Announce the Approval of a Second Indication for TAZVERIK™ (tazemetostat)

Hosted by Epizyme

WEBINAR - Multiple Broadcast Times

Learn more about a new treatment option for your relapsed or refractory follicular lymphoma (FL) patients

In this Live Broadcast, Dr. Pagel, Dr. Burke, and Dr. Kurtin will:

  • Review the Prescribing Information for this new treatment available for relapsed or refractory FL patients
  • Present clinical safety and efficacy data in this patient population
  • Provide important dosing and patient counseling information
  • Discuss a hypothetical patient case study
 
 
 

Printer-Friendly Version


Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it! 
Report Broken Link